Solaxa chosen as an 8th Annual BHCR Crab Trap Winner
Rockville, Maryland – September 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading regional innovation intermediary, is thrilled to announce […]
Researchers to study how drug can be repurposed to assess nerve injuries
Researchers at Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center are leading a clinical trial to evaluate whether
Solaxa Inc. Appoints Amy Chappel, MD, FAAN as Chief Medical Officer
Solaxa Inc. Appoints Amy Chappel, MD, FAAN as Chief Medical Officer Bethesda, MD; January 1, 2024 – Solaxa Inc. announces
Elfar Research Advances a Desperately Needed Solution for Surgeons
When severe injury causes paralysis, the best next step depends on whether nerves have been severed or crushed: unsevered nerves
Solaxa Inc. Begins Operations as a Public Benefit Corporation
Solaxa Inc. Begins Operations as a Public Benefit Corporation Bethesda, MD; February 24, 2022 – Solaxa Inc. today announces its